AbCellera Investor Presentation Deck slide image

AbCellera Investor Presentation Deck

Q3 2023 BUSINESS UPDATE COPYRIGHT © ABCELLERA 5 PARTNERSHIPS Strategic collaborations with new and existing partners. REGENERON 8 programs under contract QMULTIPLE INDICATIONS 4 new 2 completed Regeneron has exercised its rights to advance antibody candidates into further preclinical development Incyte 1 program under contract Q ONCOLOGY
View entire presentation